Correa et al. [28] described similar results for both IL-6 and IL-1β: resveratrol helped decrease the values of these interleukins in experimental periodontitis, but our study goes further, the values that better prognosis present are those of group IV, those treated with RES-SFN. Here, IL6 is linked to periodontitis.